<HashMap><database>biostudies-literature</database><scores/><additional><submitter>Peslak SA</submitter><funding>NIDDK NIH HHS</funding><funding>NHLBI NIH HHS</funding><funding>NCI NIH HHS</funding><pagination>452-465</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC9958407</full_dataset_link><repository>biostudies-literature</repository><omics_type>Unknown</omics_type><volume>31</volume><pubmed_abstract>Transcriptional enhancers can be in physical proximity of their target genes via chromatin looping. The enhancer at the β-globin locus (locus control region [LCR]) contacts the fetal-type (&lt;i>HBG&lt;/i>) and adult-type (&lt;i>HBB&lt;/i>) β-globin genes during corresponding developmental stages. We have demonstrated previously that forcing proximity between the LCR and &lt;i>HBG&lt;/i> genes in cultured adult-stage erythroid cells can activate &lt;i>HBG&lt;/i> transcription. Activation of &lt;i>HBG&lt;/i> expression in erythroid cells is of benefit to patients with sickle cell disease. Here, using the β-globin locus as a model, we provide proof of concept at the organismal level that forced enhancer rewiring might present a strategy to alter gene expression for therapeutic purposes. Hematopoietic stem and progenitor </pubmed_abstract><journal>Molecular therapy. Nucleic acids</journal><pubmed_title>Forced enhancer-promoter rewiring to alter gene expression in animal models.</pubmed_title><pmcid>PMC9958407</pmcid><funding_grant_id>R01 HL119479</funding_grant_id><funding_grant_id>T32 DK007780</funding_grant_id><funding_grant_id>R01 DK127738</funding_grant_id><funding_grant_id>R01 CA271523</funding_grant_id><funding_grant_id>R01 HL095675</funding_grant_id><funding_grant_id>K08 DK129716</funding_grant_id><pubmed_authors>Leonard A</pubmed_authors><pubmed_authors>Jiang J</pubmed_authors><pubmed_authors>Wielgosz M</pubmed_authors><pubmed_authors>Bhardwaj SK</pubmed_authors><pubmed_authors>Abdulmalik O</pubmed_authors><pubmed_authors>Demirci S</pubmed_authors><pubmed_authors>Hinds M</pubmed_authors><pubmed_authors>Bonifacino AC</pubmed_authors><pubmed_authors>Tisdale JF</pubmed_authors><pubmed_authors>Weiss MJ</pubmed_authors><pubmed_authors>Throm RE</pubmed_authors><pubmed_authors>Chandra V</pubmed_authors><pubmed_authors>Le A</pubmed_authors><pubmed_authors>Linde NS</pubmed_authors><pubmed_authors>Ferrara F</pubmed_authors><pubmed_authors>Uchida N</pubmed_authors><pubmed_authors>Chu R</pubmed_authors><pubmed_authors>Germino-Watnick P</pubmed_authors><pubmed_authors>Blobel GA</pubmed_authors><pubmed_authors>Rupon JW</pubmed_authors><pubmed_authors>Ryu B</pubmed_authors><pubmed_authors>Tong W</pubmed_authors><pubmed_authors>Hamagami N</pubmed_authors><pubmed_authors>Peslak SA</pubmed_authors><pubmed_authors>Essawi K</pubmed_authors><pubmed_authors>Krouse AE</pubmed_authors><pubmed_authors>Donahue RE</pubmed_authors></additional><is_claimable>false</is_claimable><name>Forced enhancer-promoter rewiring to alter gene expression in animal models.</name><description>Transcriptional enhancers can be in physical proximity of their target genes via chromatin looping. The enhancer at the β-globin locus (locus control region [LCR]) contacts the fetal-type (&lt;i>HBG&lt;/i>) and adult-type (&lt;i>HBB&lt;/i>) β-globin genes during corresponding developmental stages. We have demonstrated previously that forcing proximity between the LCR and &lt;i>HBG&lt;/i> genes in cultured adult-stage erythroid cells can activate &lt;i>HBG&lt;/i> transcription. Activation of &lt;i>HBG&lt;/i> expression in erythroid cells is of benefit to patients with sickle cell disease. Here, using the β-globin locus as a model, we provide proof of concept at the organismal level that forced enhancer rewiring might present a strategy to alter gene expression for therapeutic purposes. Hematopoietic stem and progenitor </description><dates><release>2023-01-01T00:00:00Z</release><publication>2023 Mar</publication><modification>2025-05-18T12:54:12.213Z</modification><creation>2025-05-18T12:54:12.213Z</creation></dates><accession>S-EPMC9958407</accession><cross_references><pubmed>36852088</pubmed><doi>10.1016/j.omtn.2023.01.016</doi></cross_references></HashMap>